semaglutide india brands Zydus Lifesciences launches injection in for diabetes, obesity treatment, ETManufacturing Novo Nordisk launches Wegovy obesity

Bottom line The December 2024 approval of generic Victoza (liraglutide) represents a significant milestone in making GLP-1 medications more accessible and affordable for people looking to manage their type 2 diabetes and lose weight

Promising therapeutics include semaglutide (Ozempic and Wegovy ), an agonist for glucagon-like peptide-1 (GLP-1) receptor, and tirzepatide (Mounjaro ), a dual agonist for GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors

Evening injections often mean nausea peaks overnight when you're sleeping, so many patients avoid daytime queasiness

About Body Contouring Body contouring at LaserAway targets areas that diet and exercise cannot fully change

This level supports energy, mental clarity, muscle tone, efficient detoxification and a healthy nervous system